The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy

Journal of Hepatology

Volumn 25, Issue 6, 1996, Pages 988-998

  Seery, John P ^a   Taylor Robinson, Simon D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROENCEPHALOGRAM; ENERGY METABOLISM; HEPATIC ENCEPHALOPATHY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0030460455     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80308-4     Document Type: Review

References (75)

1. 1. Messner, M. Management of acute hepatic encephalopathy. In: Rodes J, Arroyo V, eds. Therapy in Liver Diseases. Barcelona: Ediciones Doyma, VII, 1992; 323-30.
2. 2. Jones EA, Schafer DF. Fulminant hepatic failure. In: Zakim D, Boyer TD, eds. Hepatology, A Textbook of Liver Diseases. Philadelphia, PA: WB Saunders, 1990; 460-92.
3. 3. Fischer JE. Portal-systemic encephalopathy. In: Millward-Sadler GH, Wright R, Arthur MJP, eds. Wright's Liver and Biliary Disease. London: WB Saunders, 1992; 1262-95.
4. 4. Barbara L, Sama C, Malavolti M. The importance of recognising subclinical hepatic encephalopathy. In: Rodes J, Arroyo V, eds. Therapy in Liver Diseases. Barcelona: Ediciones Doyma, VII, 1992; 331-5.
5. 5. Conn HO. Assessment of the severity of hepatic encephalopathy. In: Rodes J, Arroyo V, eds. Therapy in Liver Diseases. Barcelona: Ediciones Doyma, 1992: 277-91.
6. 6. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind trial. Gastroenterology 1977; 72: 573-83.
7. 7. Conn HO. Trail making and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22: 541-50.
8. 8. Sherlock S, Dooley J, Diseases of the Liver and Biliary System. Oxford: Blackwell Scientific, 1993.
9. 9. Coutts GA, Cox IJ, Gadian DG, Sargentoni J, Bryant DJ, Collins AG. Phosphorus-31 magnetic resonance spectroscopy of the normal human brain. Approaches using four-dimensional chemical shift imaging and phase mapping techniques. NMR Biomed 1989; 1: 190-7.
10. 10. Ross BD, Kreis R, Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Rad 1992; 14: 128-40.
11. 11. Fazekas JF, Ticktin HE, Ehrmantraut WR, Alman RW. Cerebral metabolism in hepatic insufficiency. Am J Med 1956; 21: 843-9.
12. 12. Posner JB, Plum F. The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 1960; 39: 1246-58.
13. 13. James IM, Nashat S, Sampson D, Williams HS, Garassini I. Effect of induced metabolic alkalosis in hepatic encephalopathy. Lancet 1969; ii: 1106-08.
14. 14. Morgan MY, Jakobovits AW, James IM, Sherlock S, Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 1980; 78: 663-70.
15. 15. Hilgier W, Benveniste H, Diemer NH, Albrecht J. Decreased glucose utilisation in discrete brain regions of rat in thioacetamide-induced hepatic encephalopathy as measured with (3H)-deoxyglucose. Acta Neurol Scand 1991; 83: 353-5.
16. 16. Polli E, Bianchi Porro G, Maiolo AT. Cerebral metabolism after portacaval shunt. Lancet 1969; i: 1341-3.
17. 17. Hindfelt B, Plum F, Duffy TE. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 1977; 59: 386-96.
18. 18. Butterworth R, Giguere JE, Michaud J, Lavoie J, Pomier-Layrargues G. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12.
19. 19. Butterworth RF. Evidence that hepatic encephalopathy results from a defect of glutamatergic synaptic regulation. Mol Neuropharmacol. 1992; 2: 229-32.
20. 20. Blei AT, Traber PG. Brain edema in experimental fulminant hepatic failure. In: Butterworth RF, Pomier Layrargues G, eds. Hepatic Encephalopathy: Pathophysiology and Treatment. Clifton, NJ: Humana Press, 1989: 231-4.
21. 21. Raabe W. Synaptic transmission in ammonia intoxication. Neurochem Pathol 1987; 6: 145-66.
22. 22. Fan P, Lavoie J, Le NLO, Szerb JC, Butterworth RF. Neurochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic transmission. Neuroscience 1990; 37: 327-34.
23. 23. James JH, Escourrou J, Fischer JE. Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science 1978; 200: 1395-97.
24. 24. Mans AM, Biebuyck JF, Shelley K, Hawkins RA. Regional blood brain barrier permeability to amino acids after portacaval anastomosis. J Neurochem 1982; 38: 705-13.
25. +independent systems. J Biol Chem 1983; 258: 8949-54.
26. 26. Grippon P, LePoncin-Laffite M, Boschat M, Wang S, Faure G, Dutetre D, Opolon P. Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan. Hepatology 1986; 6: 682-6.
27. 27. Häussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 1996; 313: 697-10.
28. 28. Häussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J, Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 1475-80.
29. 29. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalography in liver disease. Lancet 1957; ii: 867-71.
30. 30. Bickford RG, Butt HR. Hepatic coma: the electroencephalographic pattern. J Clin Invest 1955; 34: 790-9.
31. 31. Romano J, Engel G. Delirium: I. Electroencephalographic data. Arch Neurol Psychiatr 1944; 51: 356-77.
32. 32. Davis H, Davis PA. The electrical activity of the brain; its relation to the psychological states and to states of impaired consciousness. J Res Nerv Ment Dis Proc 1939; 19: 580-90.
33. 33. Birchfield RI, Sicker HO, Heyman A. Alterations in blood gases during natural sleep and narcolepsy. A correlation with the electroencephalographic stages of sleep. Neurology 1958; 8: 107-12.
34. 31P N. New Engl J Med 1981; 304: 1338-42.
35. 35. Radda GK, Rajagopalan B, Taylor DJ. Biochemistry in vivo: an appraisal of clinical magnetic resonance spectroscopy. Magn Reson Q 1989; 5: 122-51.
36. 36. Gadian DG. Nuclear Magnetic Resonance and its Application to Living Systems. Oxford: Clarendon Press, 1982.
37. 37. National Radiological Protection Board. Principles for the Protection of Patients and Volunteers During Clinical Magnetic Resonance Diagnostic Procedures. Documents of the NRPB. Didcot. 1991; 2: 1-29.
38. 38. Becker ED, Fisk CL. NMR: Physical principles and current status as a biomedical technique. In Cohen SM, ed. Physiological NMR Spectroscopy: From Isolated Cells to Man. Ann. New York Acad. Sci 1987; 508: 1-9.
39. 39. Bottomley PA. The trouble with spectroscopy papers. Radiology 1991; 181: 344-50.
40. 40. Cady EB. Clinical Magnetic Resonance Spectroscopy. New York: Plenum Press, 1990: 1-45.
41. 41. Ordi dge RJ, Connelly A, Lohman JAB, Counsell C. Localised chemical shift measurements: image selected in vivo spectroscopy. J Magn Reson 1986; 66: 283-94.
42. 42. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci 1982; 79: 3523-26.
43. 43. Bailes DR, Bryant DJ, Case HA, Colons AG, Cox IJ, Evans PR, Harman RR, Khenia S, McArthur P, Oliver A, Rose MR, Ross BD, Young IR. Localised phosphorus-31 NMR spectroscopy of normal and pathological human organs in vivo using phase-encoding techniques.J Magn Reson 1987; 74: 158-70.
44. 44. Bottomley PA, Hart HR, Edelstem WA, Schenk JF, Smith LS, Leue WM, Mueller OM. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. Radiology 1984; 150: 441-6.
45. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991; 4: 109-16.
46. 31P MRS. Clin Sci 1987; 72 (Suppl 16): 26P.
47. 1H NMR spectroscopy of the human brain in chronic hepatic encephalopathy. Proc 8th Ann Mtg Soc Magn Reson Med. 1989; 1: 375.
48. 48. Chamuleau RAFM, Bosman DK, Bovée WMMJ, Luyten PR, Barkhof F. Chronic hepatic encephalopathy studied by NMR spectroscopy and MRI in man. J Hepatol 1991; 13 (Suppl 2): S19.
49. 49. Barbiroli B, Lodi R, Sama C, Bolondi L, Malavolti M, Brillanti S, Iotti S, Zaniol P, Barbara L. Abnormal brain energy metabolism detected by 31P MRS in patients with chronic liver disease. Proc 11th Ann Mtg Soc Magn Reson Med. 1992; 3: 1919.
50. 31P MRS in liver cirrhosis. Hepato-Gastroenterol.1993; 40: 6/0.
51. 51. Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 1994; 20: 1173-78.
52. 1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996; 11: 249-68.
53. 53. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992; 5: 226-33.
54. 31P magnetic resonance of the normal liver: towards in vivo biochemical pathology. Clin Sci 1992; 83: 183-90.
55. 55. Mans AM, Davis DW, Hawkins RA. Regional blood-brain-barrier transport of glucose after portacaval anastomosis. Metab Brain Dis 1986; 1: 119-28.
56. 56. Jessy J, De Joseph MR, Hawkins RA. Hyperammonaemia depresses glucose consumption throughout the brain. Biochem J 1990; 277: 693-6.
57. 57. Fazekas JF, Ticktin HE, Ehrmantraut WR, Alman RW. Cerebral metabolism in hepatic insufficiency. Am J Med 1956; 21: 843-9.
58. 58. Schenker S, McCandless DW, Brophy E, Lewis MS. Studies on the intracerebral toxicity of ammonia. J Clin Invest 1967; 46: 838-48.
59. 59. Hindfelt B, Siesj BK. Cerebral effects of acute ammonia intoxication. II: the effects upon energy metabolism. Scand J Clin Lab Invest 1971; 28: 365-74.
60. 60. Holmin T. The effect of hepatectomy on the energy state and on acid-base variables of the rat brain. Scand J Clin Lab Invest 1976; 36: 423-9.
61. 61. McCandless DW, Schenker S. Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. Exp Brain Res. 1981; 44: 325-30.
62. 62. Hindfelt B. The effect of sustained hyperammonaemia upon the metabolic state of the brain. Scand J Clin Lab Invest 1972; 30: 245-55.
63. 63. Chamuleau RA, Bosnian DK, BovØe WMMJ, Luyten PR, den Hollander JA. What the clinician can learn from MR glutamine/glutamate assays. NMR Biomed 1991; 4: 103-8.
64. 64. Kreis R, Farrow N, Ross BD. Localised 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991; 4: 109-16.
65. 65. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19-27.
66. 66. Ross BD, Kreis R, Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992; 14: 128-140.
67. 67. Ross BD, Jacobsen S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193: 457-63.
68. 68. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994; 9: 347-59.
69. 69. Kreis R, Ross BD, Farrow NA, Ackerman Z. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990; 336: 635-6.
70. 1H NMR spectroscopy: N-acetyl aspartate, creatine and choline. NMR in Biomed 1991; 4: 47-52.
71. 1H NMR spectrospecopy: N-acetyl aspartate, creatine, and choline. NMR Biomed 1991; 4: 47-52.
72. 1H spectroscopy. Glutamate and glutamine; myoinositol and related metabolites. NMR Biomed 1991; 4: 59-63.
73. 73. Hawkins RA, Jessy J, Mans AM, De Joseph MR. Effect of reducing brain glutamine synthesis on the metabolic symptoms of hepatic encephalopathy. J Neurochem 1993: 60: 1000-6.
74. 74. Ferenci P. Hepatic encephalopathy. In: McIntyre N, Benhamou, J-P, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press: 473-83.
75. 13C]glucose. J Neurochem 1994; 63: 1377-85.